Coda Octopus Group, Inc. announced that Interim Chief Financial Officer Gayle Jardine will retire effective August 3, 2026. The company appointed Mark Kelly as the new Chief Financial Officer, effective August 3, 2026, subject to a three-month probationary period. Kelly previously served as Finance Director at Medac Pharma and held senior finance roles at Chubb Insurance, Twist Bioscience Corp., and Charles River Laboratories. His compensation includes an annual base salary of approximately $218,625 and a $40,000 restricted stock grant vesting in two annual installments starting October 31, 2027. Coda Octopus Group, Inc. provides specialized imaging and sonar technology solutions.